Given the preponderance of the C/EBP eGRNs we observe in tumor paradigms, we believe that further characterization of their signaling pathways and experimental validation of their predicted gene and enhancer targets will help to study the biology of cancer. This evidence concerns the gene CEBPA and neoplasm.